Paper49654
Immunological basis for latency, recurrences and putative oncogenicity of herpes simplex virus.
Lehner T and 2 others. Lancet, 1975. Cited by 66 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Download JSON
Cite this record
ConductScience Library. Immunological basis for latency, recurrences and putative oncogenicity of herpes simplex virus. Papers, record 49654. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/49654
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immunological basis for latency, recurrences and putative oncogenicity of herpes simplex virus.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Herpes Simplex | Major topic |
| Oncogenic Viruses | Major topic |
| Simplexvirus | Major topic |
| Antibodies, Viral | |
| Antigen-Antibody Reactions | |
| Antigens, Viral | |
| Binding Sites, Antibody | |
| Cell Membrane | |
| Cell Transformation, Neoplastic | |
| Humans | |
| Immunity, Cellular | |
| Neoplasms | |
| Neurons | |
| Recurrence | |
| Virus Replication |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,216,485 | Immune responses to labial infection of BALB/c mice with herpes simplex virus type 1. | Infect Immun | 1981 | https://conductscience.org/library/papers/7216485 | PubMed |
| 7,212,769 | In vitro studies on the human cellular immune response to commercially available herpes simplex antigens. | Arch Dermatol Res | 1980 | https://conductscience.org/library/papers/7212769 | PubMed |
| 6,260,654 | Reactivation of temperature-sensitive and non-temperature-sensitive infectious bovine rhinotracheitis vaccine virus with dexamethasone. | Infect Immun | 1980 | https://conductscience.org/library/papers/6260654 | PubMed |
| 6,253,401 | Effect of immunosuppression on recurrent herpes simplex in mice. | Infect Immun | 1980 | https://conductscience.org/library/papers/6253401 | PubMed |
| 6,246,278 | Immunoglobulin G(Fc)-binding receptors on virions of herpes simplex virus type 1 and transfer of these receptors to the cell surface by infection. | J Virol | 1980 | https://conductscience.org/library/papers/6246278 | PubMed |
| 6,202,279 | Differences in antigenic properties of Fc-binding activity during infection with herpes simplex virus type 1. | Arch Virol | 1984 | https://conductscience.org/library/papers/6202279 | PubMed |
| 3,909,643 | Chemotherapy for herpes simplex virus infections. | West J Med | 1985 | https://conductscience.org/library/papers/3909643 | PubMed |
| 3,036,059 | Molecular biology and immunology of cytomegalovirus. | Biochem J | 1987 | https://conductscience.org/library/papers/3036059 | PubMed |
| 3,035,221 | Identification of a novel herpes simplex virus type 1-induced glycoprotein which complexes with gE and binds immunoglobulin. | J Virol | 1987 | https://conductscience.org/library/papers/3035221 | PubMed |
| 2,831,396 | Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI. | J Virol | 1988 | https://conductscience.org/library/papers/2831396 | PubMed |
| 2,552,134 | A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G. | J Virol | 1989 | https://conductscience.org/library/papers/2552134 | PubMed |
| 1,658,396 | Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity. | J Virol | 1991 | https://conductscience.org/library/papers/1658396 | PubMed |
| 552,474 | Symposium: oral herpes simplex virus infection. | J R Soc Med | 1979 | https://conductscience.org/library/papers/552474 | PubMed |
| 229,267 | Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein. | J Virol | 1979 | https://conductscience.org/library/papers/229267 | PubMed |
| 224,827 | [The leukocyte migration inhibition test (LMIT) in recurrent herpes simplex labialis. Comparison of the results of treatment with BCG and Levamisole (author's transl)]. | Arch Dermatol Res | 1979 | https://conductscience.org/library/papers/224827 | PubMed |
| 214,773 | Persistence in herpes simplex virus infections. | Postgrad Med J | 1978 | https://conductscience.org/library/papers/214773 | PubMed |
| 198,372 | Sequential changes in cell-mediated immune responses to herpes simplex virus after recurrent herpetic infection in humans. | Infect Immun | 1977 | https://conductscience.org/library/papers/198372 | PubMed |
| 183,627 | Pathogenetic mechansims of recurrent herpes simplex virus infections. | Arch Virol | 1976 | https://conductscience.org/library/papers/183627 | PubMed |
| 92,381 | Comparative studies on the expression of Fc-receptors, Ia antigens, and beta 2-microglobulin following in vitro herpes simplex virus infection of human lymphoid cells. | Clin Exp Immunol | 1979 | https://conductscience.org/library/papers/92381 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/49654
GET https://conductscience.org/api/papers/v1/49654/authors